FDA Approved: PATADAY ONCE DAILY RELIEF — Supplemental Application (Alcon Laboratories, Inc.)

View source ↗

Summary

FDA approved a supplemental application to expand Pataday to once-daily dosing for allergic conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• PATADAY ONCE DAILY RELIEF (OLOPATADINE HYDROCHLORIDE)

Snippet

SUPPL AP for PATADAY ONCE DAILY RELIEF (OLOPATADINE HYDROCHLORIDE)